Eric C. Hsu - Mar 4, 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Sr. VP, Pre-Clinical Res/Dev
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu
Stock symbol
INM
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 03:20 PM
Previous filing
Dec 26, 2023
Next filing
May 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -309 -0.58% $0.00 52.5K Mar 4, 2024 Common shares 309 $364.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$495 using an exchange rate of C$1.3572 = $US1.00